Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
[PMID: 26051626] PubMed record related to this compound for laboratory literature review
Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-l randomized clinical trial
"If the quantity of this product is going to be increasing, that means we're going to have more and more injectables in the environment disposed of," he said
US$ 21.37
US$ 25.11
US$ 29.67
US$ 28.81
US$ 27.46
